Hyperglycemia adversely modulates endothelial nitric oxide synthase during anesthetic preconditioning through tetrahydrobiopterin-and heat shock protein 90-mediated mechanisms

Anesthesiology

Volumn 112, Issue 3, 2010, Pages 576-585

  Amour, Julien ^a   Brzezinska, Anna K ^a   Jager, Zachary ^a   Sullivan, Corbin ^a   Weihrauch, Dorothee ^a   Du, Jianhai ^a   Vladic, Nikolina ^a   Shi, Yang ^a   Warltier, David C ^a   Pratt, Phillip F ^a   Kersten, Judy R ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; HEAT SHOCK PROTEIN 90; ISOFLURANE; N(G) NITROARGININE METHYL ESTER; OZONE; SEPIAPTERIN; TETRAHYDROBIOPTERIN;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CHEMOLUMINESCENCE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORONARY ARTERY; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART INFARCTION; HEART PROTECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMMUNOBLOTTING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION;

EID: 77649123196     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181cded1f     Document Type: Article

References (48)

1. Amour J, Brzezinska AK, Weihrauch D, Billstrom AR, Zielonka J, Krolikowski JG, Bienengraeber MW, Warltier DC, Pratt PF Jr, Kersten JR: Role of heat shock protein 90 and endothelial nitric oxide synthase during early anesthetic and ischemic preconditioning. ANESTHESIOLOGY 2009; 110:317-325
2. Gu W, Kehl F, Krolikowski JG, Pagel PS, Warltier DC, Kersten JR: Simvastatin restores ischemic preconditioning in the presence of hyperglycemia through a nitric oxide-mediated mechanism. ANESTHESIOLOGY 2008; 108:634-642
3. Chiari PC, Bienengraeber MW, Weihrauch D, Krolikowski JG, Kersten JR, Warltier DC, Pagel PS: Role of endothelial nitric oxide synthase as a trigger and mediator of isoflu-rane-induced delayed preconditioning in rabbit myocardium. ANESTHESIOLOGY 2005; 103:74-83
4. Burwell LS, Brookes PS: Mitochondria as a target for the cardioprotective effects of nitric oxide in ischemia-reper-fusion injury. Antioxid Redox Signal 2008; 10:579-599
5. McCabe TJ, Fulton D, Roman LJ, Sessa WC: Enhanced electron flux and reduced calmodulin dissociation may explain "calcium-independent" eNOS activation by phos-phorylation. J Biol Chem 2000; 275:6123-6128
6. Giugliano D, Marfella R, Coppola L, Verrazzo G, Acampora R, Giunta R, Nappo F, Lucarelli C, D'Onofrio F: Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 1997; 95:1783-1790
7. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC Jr, Sowers JR: Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation 1999; 100:1134-1146
8. Kehl F, Krolikowski JG, Weihrauch D, Pagel PS, Warltier DC, Kersten JR: N-acetylcysteine restores isoflurane-in-duced preconditioning against myocardial infarction during hyperglycemia. ANESTHESIOLOGY 2003; 98:1384-1390
9. Pritchard KA Jr, Ackerman AW, Gross ER, Stepp DW, Shi Y, Fontana JT, Baker JE, Sessa WC: Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase. J Biol Chem 2001; 276:17621-17624
10. Chen JX, Lawrence ML, Cunningham G, Christman BW, Meyrick B: HSP90 and Akt modulate Ang-1-induced angio-genesis via NO in coronary artery endothelium. J Appl Physiol 2004; 96:612-620 (Pubitemid 38140163)
11. Chen JX, Meyrick B: Hypoxia increases Hsp90 binding to eNOS via PI3K-Akt in porcine coronary artery endothe-lium. Lab Invest 2004; 84:182-190
12. Lei H, Venkatakrishnan A, Yu S, Kazlauskas A: Protein kinase A-dependent translocation of Hsp90 alpha impairs endothelial nitric-oxide synthase activity in high glucose and diabetes. J Biol Chem 2007; 282:9364-9371
13. Satoh M, Fujimoto S, Haruna Y, Arakawa S, Horike H, Komai N, Sasaki T, Tsujioka K, Makino H, Kashihara N: NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol 2005; 288:F1144-52
14. Ihlemann N, Rask-Madsen C, Perner A, Dominguez H, Hermann T, Kober L, Torp-Pedersen C: Tetrahydrobiop-terin restores endothelial dysfunction induced by an oral glucose challenge in healthy subjects. Am J Physiol Heart Circ Physiol 2003; 285:H875-82
15. Bagi Z, Toth E, Koller A, Kaley G: Microvascular dysfunction after transient high glucose is caused by superoxide-dependent reduction in the bioavailability of NO and BH(4). Am J Physiol Heart Circ Physiol 2004; 287:H626-33
16. Heitzer T, Krohn K, Albers S, Meinertz T: Tetrahydrobiop-terin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with type II diabetes mellitus. Diabetologia 2000; 43:1435-1438
17. Pannirselvam M, Simon V, Verma S, Anderson T, Triggle CR: Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice. Br J Pharmacol 2003; 140:701-706
18. Cosentino F, Hurlimann D, Delli Gatti C, Chenevard R, Blau N, Alp NJ, Channon KM, Eto M, Lerch P, Enseleit F, Ruschitzka F, Volpe M, Luscher TF, Noll G: Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia. Heart 2008; 94:487-492
19. Fukuda Y, Teragawa H, Matsuda K, Yamagata T, Matsuura H, Chayama K: Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercho-lesterolaemia. Heart 2002; 87:264-269 (Pubitemid 34177685)
20. Chiari PC, Pagel PS, Tanaka K, Krolikowski JG, Ludwig LM, Trillo RA Jr, Puri N, Kersten JR, Warltier DC: Intravenous emulsified halogenated anesthetics produce acute and delayed preconditioning against myocardial infarction in rabbits. ANESTHESIOLOGY 2004; 101:1160-1166
21. Qu XW, Thaete LG, Rozenfeld RA, Zhu Y, De Plaen IG, Caplan MS, Hsueh W: Tetrahydrobiopterin prevents platelet-activating factor-induced intestinal hypoperfusion and necrosis: Role of neuronal nitric oxide synthase. Crit Care Med 2005; 33:1050-1056
22. Tang XL, Takano H, Xuan YT, Sato H, Kodani E, Dawn B, Zhu Y, Shirk G, Wu WJ, Bolli R: Hypercholesterolemia abrogates late preconditioning via a tetrahydrobiopterin-dependent mechanism in conscious rabbits. Circulation 2005; 112:2149-2156
23. Tanaka K, Weihrauch D, Kehl F, Ludwig LM, LaDisa JF Jr, Kersten JR, Pagel PS, Warltier DC: Mechanism of preconditioning by isoflurane in rabbits: A direct role for reactive oxygen species. ANESTHESIOLOGY 2002; 97:1485-1490
24. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM: Activation of nitric oxide synthase in endothe-lial cells by Akt-dependent phosphorylation. Nature 1999; 399:601-605
25. Sessa WC, Garcia-Cardena G, Liu J, Keh A, Pollock JS, Bradley J, Thiru S, Braverman IM, Desai KM: The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric oxide. J Biol Chem 1995; 270:17641-17644
26. Whitsett J, Picklo MJS, Vasquez-Vivar J: 4-Hydroxy-2-non-enal increases superoxide anion radical in endothelial cells via stimulated GTP cyclohydrolase proteasomal degradation. Arterioscler Thromb Vasc Biol 2007; 27:2340-2347
27. Crabtree MJ, Smith CL, Lam G, Goligorsky MS, Gross SS: Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiop-terin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS. Am J Physiol Heart Circ Physiol 2008; 294:H1530-40
28. Lerman A, Zeiher AM: Endothelial function: Cardiac events. Circulation 2005; 111:363-368
29. Alp NJ, Mussa S, Khoo J, Cai S, Guzik T, Jefferson A, Goh N, Rockett KA, Channon KM: Tetrahydrobiopterin-depen-dent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohy-drolase I overexpression. J Clin Invest 2003; 112:725-735
30. Schulz E, Jansen T, Wenzel P, Daiber A, Munzel T: Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothe-lial dysfunction in hypertension. Antioxid Redox Signal 2008; 10:1115-1126
31. Blackwell KA, Sorenson JP, Richardson DM, Smith LA, Suda O, Nath K, Katusic ZS: Mechanisms of aging-induced impairment of endothelium-dependent relaxation: Role of tetrahydrobiopterin. Am J Physiol Heart Circ Physiol 2004; 287:H2448-53
32. Heitzer T, Brockhoff C, Mayer B, Warnholtz A, Mollnau H, Henne S, Meinertz T, Munzel T: Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers: Evidence for a dysfunctional nitric oxide syn-thase. Circ Res 2000; 86:E36-41
33. Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, Kersten JR: Hyperglycemia prevents isoflurane-induced preconditioning against myocardial infarction. ANESTHESI-OLOGY 2002; 96:183-188 (Pubitemid 34032499)
34. Kersten JR, Montgomery MW, Ghassemi T, Gross ER, Toller WG, Pagel PS, Warltier DC: Diabetes and hyperglycemia impair activation of mitochondrial K(ATP) channels. Am J Physiol Heart Circ Physiol 2001; 280:H1744-50
35. Bevers LM, Braam B, Post JA, van Zonneveld AJ, Rabelink TJ, Koomans HA, Verhaar MC, Joles JA: Tetrahydrobiop-terin, but not L-arginine, decreases NO synthase uncoupling in cells expressing high levels of endothelial NO synthase. Hypertension 2006; 47:87-94
36. Forstermann U: Janus-faced role of endothelial NO synthase in vascular disease: Uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal. Biol Chem 2006; 387:1521-1533
37. Whitsett J, Martasek P, Zhao H, Schauer DW, Hatakeyama K, Kalyanaraman B, Vasquez-Vivar J: Endothelial cell superoxide anion radical generation is not dependent on endothelial nitric oxide synthase-serine 1179 phosphorylation and endothelial nitric oxide synthase dimer/mono-mer distribution. Free Radic Biol Med 2006; 40:2056-2068
38. Wever RM, Luscher TF, Cosentino F, Rabelink TJ: Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation 1998; 97:108-112
39. Milstien S, Katusic Z: Oxidation of tetrahydrobiopterin by peroxynitrite: Implications for vascular endothelial function. Biochem Biophys Res Commun 1999; 263:681-684
40. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T, Harrison DG: Endothelial regulation of vasomotion in apoE-deficient mice: Implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 2001; 103:1282-1288
41. Bagi Z, Koller A: Lack of nitric oxide mediation of flow-dependent arteriolar dilation in type I diabetes is restored by sepiapterin. J Vasc Res 2003; 40:47-57
42. Cai S, Khoo J, Channon KM: Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells. Cardiovasc Res 2005; 65:823-831
43. Shi W, Meininger CJ, Haynes TE, Hatakeyama K, Wu G: Regulation of tetrahydrobiopterin synthesis and bioavailability in endothelial cells. Cell Biochem Biophys 2004; 41:415-434
44. Dumitrescu C, Biondi R, Xia Y, Cardounel AJ, Druhan LJ, Ambrosio G, Zweier JL: Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4. Proc Natl Acad Sci USA 2007; 104:15081-15086
45. Verma S, Maitland A, Weisel RD, Fedak PW, Pomroy NC, Li SH, Mickle DA, Li RK, Rao V: Novel cardioprotective effects of tetrahydrobiopterin after anoxia and reoxygen-ation: Identifying cellular targets for pharmacologic manipulation. J Thorac Cardiovasc Surg 2002; 123:1074-1083
46. Sasaki N, Yamashita T, Takaya T, Shinohara M, Shiraki R, Takeda M, Emoto N, Fukatsu A, Hayashi T, Ikemoto K, Nomura T, Yokoyama M, Hirata K, Kawashima S: Augmentation of vascular remodeling by uncoupled endothelial nitric oxide synthase in a mouse model of diabetes melli-tus. Arterioscler Thromb Vasc Biol 2008; 28:1068-1076
47. 2~ through endothelial GTPCH1 and NADPH oxidase. Life Sci 2004; 75:3185-3194
48. Lucchinetti E, Ambrosio S, Aguirre J, Herrmann P, Harter L, Keel M, Meier T, Zaugg M: Sevoflurane inhalation at sedative concentrations provides endothelial protection against ischemia-reperfusion injury in humans. ANESTHESIOLOGY 2007; 106:262-268